The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 01, 2020
Ampio announced the third group in the Phase I inhaled Ampion clinical study is being treated following clearance by the SMC who found Ampion to be ...
read more
Monday, November 30, 2020
BrainStorm Cell announced topline results from the Company's randomized, double-blind placebo-controlled Phase 3 trial evaluating NurOwn as a ...
read more
Monday, November 30, 2020
Moderna announced the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the ...
read more
Monday, November 30, 2020
PTC announced the initiation of a Phase 1 clinical trial to evaluate PTC518 in healthy volunteers for Huntington's disease.
read more
Friday, November 27, 2020
PLx Pharma announced two CMC sNDAs have been submitted to the FDA.
read more
Friday, November 27, 2020
RedHill Biopharma announced the FDA has cleared the Company's IND application for a Phase 2/3 study evaluating RHB-107 for COVID-19.
read more
Thursday, November 26, 2020
Aeterna Zentaris has entered into an amendment of its existing License Agreement with Novo Nordisk related to the development and commercialization of...
read more
Wednesday, November 25, 2020
Agios announced the FDA has granted orphan drug designation to the company’s first-in-class PKR activator mitapivat for the treatment of patients with...
read more
Wednesday, November 25, 2020
Johnson & Johnson announced the expansion to the partnership between Janssen and the BARDA for the ongoing development of Janssen's investigational ...
read more
Wednesday, November 25, 2020
BE, Dynavax, and Baylor College announced BE has initiated a trial of its COVID-19 subunit vaccine candidate in India.
read more
Wednesday, November 25, 2020
Apellis announced the FDA has accepted and granted Priority Review designation for the NDA for pegcetacoplan for the treatment of paroxysmal nocturnal...
read more
Tuesday, November 24, 2020
AstraZeneca Pharmaceuticals
Positive high-level results from an interim analysis of clinical trials of AstraZeneca’s COVID-19 vaccine in the UK and Brazil showed the vaccine was ...
read more
Monday, November 23, 2020
Pfizer and BioNTech will submit a request to the FDA for EUA of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2.
read more
Monday, November 23, 2020
Novartis has entered into an agreement with Mesoblast to develop, commercialize and manufacture remestemcel-L for ARDS, including that associated with...
read more
Monday, November 23, 2020
Sagent has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate for COVID-19 in high-risk outpatients and has ...
read more